首页> 外文期刊>Journal of the American Chemical Society >Emerging Frontiers in Drug Delivery
【24h】

Emerging Frontiers in Drug Delivery

机译:药物输送的新兴领域

获取原文
获取原文并翻译 | 示例
       

摘要

Medicine relies on the use of pharmacologically active agents (drugs) to manage and treat disease. However, drugs are not inherently effective; the benefit of a drug is directly related to the mariner by which it is administered or delivered. Drug delivery can affect drug pharmacokinetics, absorption, distribution, metabolism, duration of therapeutic effect, excretion, and toxicity. As new therapeutics (e.g., biologics) are being developed, there is an accompanying need for improved chemistries and materials to deliver them to the target site in the body, at a therapeutic concentration, and for the required period of time. In this Perspective, we provide an historical overview of drug delivery and controlled release followed by highlights of four emerging areas in the field of drug delivery: systemic RNA delivery, drug delivery for localized therapy, oral drug delivery systems, and biologic drug delivery systems. In each case, we present the barriers to effective drug delivery as well as chemical and materials advances that are enabling the field to overcome these hurdles for clinical impact.
机译:医学依赖于使用药理活性剂(药物)来控制和治疗疾病。但是,药物并不是天生的有效药物。药物的利益与给药或给药的水手直接相关。药物输送会影响药物的药代动力学,吸收,分布,代谢,疗效持续时间,排泄和毒性。随着新疗法(例如生物制剂)的开发,随之而来的是需要改进的化学和材料以治疗浓度和所需的时间段将它们递送到体内的靶部位。在此观点中,我们提供了药物输送和控释的历史概述,然后重点介绍了药物输送领域中的四个新兴领域:系统性RNA输送,用于局部治疗的药物输送,口服药物输送系统和生物药物输送系统。在每种情况下,我们都提出了有效药物输送的障碍以及化学和材料方面的进展,这些都使该领域克服了临床影响的这些障碍。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2016年第3期|704-717|共14页
  • 作者单位

    Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, United States,Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, United States;

    Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States,Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States;

    Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, United States,Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, United States,Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:08:37

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号